SYSTEMIC MITOMYCIN C VERSUS CISPLATIN: COMPARISON OF ANTITUMOR ACTIVITY IN PRIMARY MURINE BLADDER CANCERHOPKINS SC; MATHENY R; SOLOWAY MS et al.1982; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1982; VOL. 20; NO 2; PP. 157-159; BIBL. 12 REF.Article

CARCINOMA OF THE FEMALE URETHRA: REASSESSMENT OF MODES OF THERAPY = CANCER DE L'URETHRE FEMININ: REAPPRECIATION DES MODALITES THERAPEUTIQUESHOPKINS SC; VIDER M; NAG SK et al.1983; JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1983; VOL. 129; NO 5; PP. 958-961; ABS. ENG; BIBL. 16 REF.; GRAPH, FIGArticle

SERIAL SPOT HYDROXYPROLINE/CREATININE RATIOS IN METASTATIC PROSTATIC CANCER = DOSAGE EN SERIE DU RAPPORT HYDROXYPROLINE/CREATININE DANS LE CANCER METASTATIQUE DE LA PROSTATEHOPKINS SC; NISSENKORN I; PALMIERI GMA et al.1983; JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1983; VOL. 129; NO 2; PP. 319-323; ABS. ENG; BIBL. 29 REF.; GRAPHArticle